A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants
Status:
Completed
Trial end date:
2017-12-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether taking lasmiditan and sumatriptan together
will have any additional effects on heart rate and blood pressure compared to taking
lasmiditan and sumatriptan individually. This study will also look at the amount of study
drug that gets into the blood stream and how long it takes the body to get rid of it when
these two drugs are taken together.
This study will last about 21 days, not including the screening. Participants will spend 16
days/15 nights in the clinical research unit (CRU) followed by follow-up. Screening is
required within 28 days prior to the start of the study.